Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1988 Apr;51(4):549–551. doi: 10.1136/jnnp.51.4.549

Cerebrospinal fluid neuron-specific enolase is decreased in multi-infarct dementia, but unchanged in Alzheimer's disease.

R Sulkava 1, L Viinikka 1, T Erkinjuntti 1, R Roine 1
PMCID: PMC1032972  PMID: 3379429

Abstract

Cerebrospinal fluid (CSF) levels of neuron-specific enolase (NSE) were measured in 22 patients with probable Alzheimer's disease and in 35 patients with multi-infarct dementia, and in 15 controls. CSF NSE in patients with Alzheimer's disease did not differ from those in controls. In patients with multi-infarct dementia without recent vascular events CSF NSE was lower than in controls or in Alzheimer patients. This finding is in accord with the prevailing opinion that vascular dementia is caused by multiple infarcts and not by continuous neuronal ischaemia.

Full text

PDF
550

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bowen D. M., White P., Spillane J. A., Goodhardt M. J., Curzon G., Iwangoff P., Meier-Ruge W., Davison A. N. Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet. 1979 Jan 6;1(8106):11–14. doi: 10.1016/s0140-6736(79)90454-9. [DOI] [PubMed] [Google Scholar]
  2. Cutler N. R., Kay A. D., Marangos P. J., Burg C. Cerebrospinal fluid neuron-specific enolase is reduced in Alzheimer's disease. Arch Neurol. 1986 Feb;43(2):153–154. doi: 10.1001/archneur.1986.00520020047017. [DOI] [PubMed] [Google Scholar]
  3. Erkinjuntti T., Ketonen L., Sulkava R., Sipponen J., Vuorialho M., Iivanainen M. Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry. 1987 Jan;50(1):37–42. doi: 10.1136/jnnp.50.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Erkinjuntti T., Laaksonen R., Sulkava R., Syrjäläinen R., Palo J. Neuropsychological differentiation between normal aging, Alzheimer's disease and vascular dementia. Acta Neurol Scand. 1986 Nov;74(5):393–403. doi: 10.1111/j.1600-0404.1986.tb03532.x. [DOI] [PubMed] [Google Scholar]
  5. Erkinjuntti T., Wikström J., Palo J., Autio L. Dementia among medical inpatients. Evaluation of 2000 consecutive admissions. Arch Intern Med. 1986 Oct;146(10):1923–1926. [PubMed] [Google Scholar]
  6. Hachinski V. C., Lassen N. A., Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet. 1974 Jul 27;2(7874):207–210. doi: 10.1016/s0140-6736(74)91496-2. [DOI] [PubMed] [Google Scholar]
  7. Hay E., Royds J. A., Davies-Jones G. A., Lewtas N. A., Timperley W. R., Taylor C. B. Cerebrospinal fluid enolase in stroke. J Neurol Neurosurg Psychiatry. 1984 Jul;47(7):724–729. doi: 10.1136/jnnp.47.7.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Marangos P. J., Zis A. P., Clark R. L., Goodwin F. K. Neuronal, non-neuronal and hybrid forms of enolase in brain: structural, immunological and functional comparisons. Brain Res. 1978 Jul 7;150(1):117–133. doi: 10.1016/0006-8993(78)90657-1. [DOI] [PubMed] [Google Scholar]
  9. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  10. Mokuno K., Kato K., Kawai K., Matsuoka Y., Yanagi T., Sobue I. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci. 1983 Aug-Sep;60(3):443–451. doi: 10.1016/0022-510x(83)90155-7. [DOI] [PubMed] [Google Scholar]
  11. Royds J. A., Davies-Jones G. A., Lewtas N. A., Timperley W. R., Taylor C. B. Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system. J Neurol Neurosurg Psychiatry. 1983 Nov;46(11):1031–1036. doi: 10.1136/jnnp.46.11.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schmechel D., Marangos P. J., Zis A. P., Brightman M., Goodwin F. K. Brain endolases as specific markers of neuronal and glial cells. Science. 1978 Jan 20;199(4326):313–315. doi: 10.1126/science.339349. [DOI] [PubMed] [Google Scholar]
  13. Steinberg R., Gueniau C., Scarna H., Keller A., Worcel M., Pujol J. F. Experimental brain ischemia: neuron-specific enolase level in cerebrospinal fluid as an index of neuronal damage. J Neurochem. 1984 Jul;43(1):19–24. doi: 10.1111/j.1471-4159.1984.tb06673.x. [DOI] [PubMed] [Google Scholar]
  14. Sulkava R., Haltia M., Paetau A., Wikström J., Palo J. Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry. 1983 Jan;46(1):9–13. doi: 10.1136/jnnp.46.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES